Cvi Holdings, LLC Contrafect Corp Transaction History

Cvi Holdings, LLC

  • $11.5 Million
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021
SELL
$5.05 - $6.4 $2.85 Million - $3.61 Million
-563,720 Closed
0 $0
Q3 2020

Nov 16, 2020
SELL
$5.05 - $6.99 $4.92 Million - $6.82 Million
-974,965 Reduced 63.36%
563,720 $2.98 Million
Q2 2020

Aug 14, 2020
BUY
$4.69 - $7.81 $7.22 Million - $12 Million
1,538,685 New
1,538,685 $9.83 Million

Others Institutions Holding CFRX

# of Institutions
2
Shares Held
49.2K
Call Options Held
0
Put Options Held
0
View Full List

About CONTRAFECT Corp

CFRX Quotes by TradingView
  • Ticker CFRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,332,700
  • Market Cap $1.18M
  • Description
  • ContraFect Corporation, a clinical-stage biotechnology company, discovers and develops therapeutic protein and antibody products for the treatment of life-threatening and drug-resistant infectious diseases in the United States. Its lead program includes Exebacase, a lysin, which is in Phase III clinical trials for the treatment of staphylococcus...
More about CFRX
Track This Portfolio

Track Cvi Holdings, LLC Portfolio

Follow Cvi Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cvi Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cvi Holdings, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email